Indeed, fibrosis has been observed in diabetic patients with NAFLD even independently of NASH [6], and genetic variants that impair insulin receptor (InsR) signaling favor fibrosis development in NAFLD patients [8]. Here, INSR is linked to metabolic dysfunction-associated steatohepatitis.